AGA Medical to Report Third Quarter Earnings on Monday, November 8, 2010
29 October 2010 - 7:30AM
Business Wire
AGA Medical Holdings, Inc. (AGA Medical) (Nasdaq: AGAM) will
issue an earnings release to report its third quarter operating
results on Monday, November 8, 2010 at approximately 4:30 p.m. ET
(3:30 p.m. CT).
On October 20, 2010, St. Jude Medical, Inc. and AGA Medical
announced that the Boards of Directors of both companies approved a
definitive agreement under which St. Jude Medical, Inc. will
acquire all of the outstanding shares of AGA Medical for $20.80 per
share in a cash and stock transaction. In light of this
announcement, AGA Medical will not host a webcast or conference
call to discuss its third quarter operating results.
To access the press release once issued, please go to the
investor relations section of the AGA Medical website
(www.amplatzer.com). The press release will also be filed on Form
8-K on Tuesday, November 9, 2010 which will be available on the
company’s website and on the SEC’s website (www.sec.gov).
Additional Information about the Proposed Transaction and
Where to Find It
In connection with the exchange offer, St. Jude Medical has
filed with the SEC a Registration Statement on Form S-4 and a
Tender Offer Statement on Schedule TO, and AGA Medical has filed a
Solicitation/Recommendation Statement on Schedule 14D-9.
INVESTORS AND STOCKHOLDERS ARE URGED TO READ THESE DOCUMENTS
CAREFULLY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT ST. JUDE
MEDICAL, AGA MEDICAL AND THE PROPOSED TRANSACTION. This news
release is for informational purposes only and does not constitute
an offer to purchase, or a solicitation of an offer to sell shares
of common stock of AGA Medical in any jurisdiction where such
activities would be unlawful under the relevant laws in that
jurisdiction, nor is it a substitute for the Registration
Statement, Schedule TO, and Schedule 14D-9.
Investors and stockholders may obtain free copies of the
Registration Statement on Form S-4, the Schedule TO and Schedule
14D-9 as well as other filings containing information about St.
Jude Medical and AGA Medical without charge at the SEC’s website
(www.sec.gov).
A free copy of the exchange offer materials are also available
on St. Jude Medical’s website at www.sjm.com and a copy of the
Schedule 14D-9 is available on AGA Medical’s website at
www.amplatzer.com. Copies of the exchange offer materials may also
be obtained free of charge from Georgeson, Inc., the information
agent for the exchange offer, by calling toll-free at (877)
278-4774 (brokers and bankers call, (212) 440-9800).
About AGA Medical
AGA Medical, based in Plymouth, Minnesota, is a leading
innovator and manufacturer of medical devices for the treatment of
structural heart defects and vascular abnormalities. AGA Medical’s
AMPLATZER® occlusion devices offer minimally invasive,
transcatheter treatments that have been clinically shown to be safe
and highly effective in defect closure. AGA Medical is the only
manufacturer with occlusion devices approved to close seven
different structural heart defects, with leading market positions
for each of its devices. More than 1,650 articles supporting the
benefits of AMPLATZER products have been published in medical
literature. AGA Medical markets its AMPLATZER products in 112
countries worldwide to interventional cardiologists,
electrophysiologists, interventional radiologists and vascular
surgeons. More information about the company and its products can
be found at http://www.amplatzer.com.
Aga Medical Holdings Com (MM) (NASDAQ:AGAM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aga Medical Holdings Com (MM) (NASDAQ:AGAM)
Historical Stock Chart
From Sep 2023 to Sep 2024